Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis

Barbara M. Schreiber, Mara Veverbrants, Richard E. Fine, Jan K. Blusztajn, Mario Salmona, Apurva Patel, Jean D. Sipe

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The addition of acute-phase apolipoprotein serum amyloid A (SAA) to cultured aortic smooth-muscle cells caused a decrease in the incorporation of [ 14C]acetate into lipids. Optimal inhibition of lipid biosynthesis was achieved with 2 μM SAA, and the effect was maintained for up to 1 week when SAA was included in the culture medium. Lipid extracts were subjected to TLC and it was determined that the SAA-induced decrease in [ 14C]acetate incorporation into lipids was attributable to decreases in cholesterol, phospholipid and triglyceride levels. The accumulated mass of cholesterol and phospholipid in SAA-treated cultures was significantly less than that of controls, with no change in the accumulated protein. Moreover, SAA had no effect on either protein synthesis or DNA synthesis, suggesting that SAA specifically alters lipid synthesis. By using a peptide corresponding to the cholesterol-binding domain of acute-phase SAA (amino acids 1-18), it was shown that this region of the molecule was as effective as the full-length protein in decreasing lipid synthesis and the accumulation of cholesterol and phospholipid. The implications of these findings for atherosclerosis and Alzheimer's disease are discussed.

Original languageEnglish
Pages (from-to)7-13
Number of pages7
JournalBiochemical Journal
Volume344
Issue number1
DOIs
Publication statusPublished - Nov 15 1999

Fingerprint

Serum Amyloid A Protein
Apolipoproteins
Biosynthesis
Smooth Muscle Myocytes
Muscle
Down-Regulation
Cells
Lipids
Cholesterol
Phospholipids
Acetates
Proteins
Culture Media
Atherosclerosis
Alzheimer Disease
Triglycerides
Amino Acids
Peptides
Molecules
DNA

Keywords

  • Atherosclerosis
  • Cholesterol
  • Fatty acids
  • Inflammation
  • Phospholipids

ASJC Scopus subject areas

  • Biochemistry

Cite this

Schreiber, B. M., Veverbrants, M., Fine, R. E., Blusztajn, J. K., Salmona, M., Patel, A., & Sipe, J. D. (1999). Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis. Biochemical Journal, 344(1), 7-13. https://doi.org/10.1042/0264-6021:3440007

Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis. / Schreiber, Barbara M.; Veverbrants, Mara; Fine, Richard E.; Blusztajn, Jan K.; Salmona, Mario; Patel, Apurva; Sipe, Jean D.

In: Biochemical Journal, Vol. 344, No. 1, 15.11.1999, p. 7-13.

Research output: Contribution to journalArticle

Schreiber, BM, Veverbrants, M, Fine, RE, Blusztajn, JK, Salmona, M, Patel, A & Sipe, JD 1999, 'Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis', Biochemical Journal, vol. 344, no. 1, pp. 7-13. https://doi.org/10.1042/0264-6021:3440007
Schreiber, Barbara M. ; Veverbrants, Mara ; Fine, Richard E. ; Blusztajn, Jan K. ; Salmona, Mario ; Patel, Apurva ; Sipe, Jean D. / Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis. In: Biochemical Journal. 1999 ; Vol. 344, No. 1. pp. 7-13.
@article{9cd5a97e1d7842eeb33c7f91f06b2ee3,
title = "Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis",
abstract = "The addition of acute-phase apolipoprotein serum amyloid A (SAA) to cultured aortic smooth-muscle cells caused a decrease in the incorporation of [ 14C]acetate into lipids. Optimal inhibition of lipid biosynthesis was achieved with 2 μM SAA, and the effect was maintained for up to 1 week when SAA was included in the culture medium. Lipid extracts were subjected to TLC and it was determined that the SAA-induced decrease in [ 14C]acetate incorporation into lipids was attributable to decreases in cholesterol, phospholipid and triglyceride levels. The accumulated mass of cholesterol and phospholipid in SAA-treated cultures was significantly less than that of controls, with no change in the accumulated protein. Moreover, SAA had no effect on either protein synthesis or DNA synthesis, suggesting that SAA specifically alters lipid synthesis. By using a peptide corresponding to the cholesterol-binding domain of acute-phase SAA (amino acids 1-18), it was shown that this region of the molecule was as effective as the full-length protein in decreasing lipid synthesis and the accumulation of cholesterol and phospholipid. The implications of these findings for atherosclerosis and Alzheimer's disease are discussed.",
keywords = "Atherosclerosis, Cholesterol, Fatty acids, Inflammation, Phospholipids",
author = "Schreiber, {Barbara M.} and Mara Veverbrants and Fine, {Richard E.} and Blusztajn, {Jan K.} and Mario Salmona and Apurva Patel and Sipe, {Jean D.}",
year = "1999",
month = "11",
day = "15",
doi = "10.1042/0264-6021:3440007",
language = "English",
volume = "344",
pages = "7--13",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "1",

}

TY - JOUR

T1 - Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis

AU - Schreiber, Barbara M.

AU - Veverbrants, Mara

AU - Fine, Richard E.

AU - Blusztajn, Jan K.

AU - Salmona, Mario

AU - Patel, Apurva

AU - Sipe, Jean D.

PY - 1999/11/15

Y1 - 1999/11/15

N2 - The addition of acute-phase apolipoprotein serum amyloid A (SAA) to cultured aortic smooth-muscle cells caused a decrease in the incorporation of [ 14C]acetate into lipids. Optimal inhibition of lipid biosynthesis was achieved with 2 μM SAA, and the effect was maintained for up to 1 week when SAA was included in the culture medium. Lipid extracts were subjected to TLC and it was determined that the SAA-induced decrease in [ 14C]acetate incorporation into lipids was attributable to decreases in cholesterol, phospholipid and triglyceride levels. The accumulated mass of cholesterol and phospholipid in SAA-treated cultures was significantly less than that of controls, with no change in the accumulated protein. Moreover, SAA had no effect on either protein synthesis or DNA synthesis, suggesting that SAA specifically alters lipid synthesis. By using a peptide corresponding to the cholesterol-binding domain of acute-phase SAA (amino acids 1-18), it was shown that this region of the molecule was as effective as the full-length protein in decreasing lipid synthesis and the accumulation of cholesterol and phospholipid. The implications of these findings for atherosclerosis and Alzheimer's disease are discussed.

AB - The addition of acute-phase apolipoprotein serum amyloid A (SAA) to cultured aortic smooth-muscle cells caused a decrease in the incorporation of [ 14C]acetate into lipids. Optimal inhibition of lipid biosynthesis was achieved with 2 μM SAA, and the effect was maintained for up to 1 week when SAA was included in the culture medium. Lipid extracts were subjected to TLC and it was determined that the SAA-induced decrease in [ 14C]acetate incorporation into lipids was attributable to decreases in cholesterol, phospholipid and triglyceride levels. The accumulated mass of cholesterol and phospholipid in SAA-treated cultures was significantly less than that of controls, with no change in the accumulated protein. Moreover, SAA had no effect on either protein synthesis or DNA synthesis, suggesting that SAA specifically alters lipid synthesis. By using a peptide corresponding to the cholesterol-binding domain of acute-phase SAA (amino acids 1-18), it was shown that this region of the molecule was as effective as the full-length protein in decreasing lipid synthesis and the accumulation of cholesterol and phospholipid. The implications of these findings for atherosclerosis and Alzheimer's disease are discussed.

KW - Atherosclerosis

KW - Cholesterol

KW - Fatty acids

KW - Inflammation

KW - Phospholipids

UR - http://www.scopus.com/inward/record.url?scp=0033571709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033571709&partnerID=8YFLogxK

U2 - 10.1042/0264-6021:3440007

DO - 10.1042/0264-6021:3440007

M3 - Article

C2 - 10548527

AN - SCOPUS:0033571709

VL - 344

SP - 7

EP - 13

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 1

ER -